Refine by
Gene Editing Therapy Suppliers Serving Mauritius
63 companies found
based inShirley, NEW YORK (USA)
CD BioSciences is a leading customer-focused biotechnology company founded in New York. Virus-like particles (VLPs) constructed on plant-based platforms can be produced on a large scale as plants can be grown cheaply and efficiently without the need ...
cVLPs are formed from VLPs and ligands through genetic fusion or chemical conjugation. As a leading global provider of custom services, CD BioSciences has advanced facilities and experienced scientists dedicated to cVLPs development services to help ...
based inBielefeld, GERMANY
PlasmidFactory GmbH & Co. KG is a globally active biopharmaceutical company, founded in Bielefeld, Germany, in 2000. The leading contract manufacturing organization (CMO) for plasmid and minicircle DNA has a strong customer base in the fields of ...
Minicircles (MC) are circular DNA molecules that are generated by an intramolecular (cis-) recombination from a parental plasmid (PP). The difference between MC and standard plasmid vectors for gene therapy or nucleic acid vaccination is that the MC ...
based inGembloux, BELGIUM
Aseptic Technologies specializes in providing innovative aseptic solutions for the biotech and pharmaceutical industry. As a member of the SKAN Group, the company supports the delivery of advanced therapies by offering expertise in injection molding ...
based inShanghai City, CHINA
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ('Fosun Pharma'; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates ...
based inColumbus, OHIO (USA)
Andelyn Biosciences is a biopharmaceutical CDMO Pioneering Solutions That Turn Hope into Reality™. With 20+ years of experience manufacturing viral vectors, Andelyn’s scientific expertise for development and characterization has led to GMP material ...
Andelyn Biosciences provides clients with a broad range of viral vector manufacturing platforms and solutions, including AAV and Lentiviral adherent and suspension systems along with plasmid manufacturing. We support our clients throughout every ...
based inBinjiang, Hangzhou, CHINA
A LEADING SOLUTION PROVIDER IN LIFESCIENCE FIELD Founded in 2002, Tailin (ZheJiangTailin Bioengineering Co., Ltd.) provides isolation technology for pharmaceutical production, ATMP research, and laboratories. Tailin perhaps is the only one who ...
Design based on stringent GMP aseptic production requirements and meets the requirements of various regulatory agencies (FDA, EMA, NMPA) regulations and industry guidelines (ISO, PDA, USP, Chinese ...
based inCranbury, NEW JERSEY (USA)
Advancing an integrated pipeline of genetic therapies that correct the root cause of complex and rare life-threatening childhood disorders. Our mission is to develop first-in-class and best-in-class, curative gene therapies for patients with ...
Danon Disease (DD) is a rare genetic disorder that is characterized by severe and primarily hypertrophic cardiomyopathy. Skeletal muscle weakness and mild cognitive impairment are also common. The causative mutation has been identified in the gene ...
based inAlpharetta, GEORGIA (US) (USA)
phasetwo specializes in providing advanced storage solutions engineered with a user-centric approach, specifically targeting the Life Science sectors. Their portfolio includes a variety of cryogenic and cold storage products tailored for ...
based inDallas, TEXAS (USA)
Lupagen is a privately held early stage biotech company developing first-in-class bedside enabled cell & gene therapies (CAR-T cell, gene editing and immunotherapy products) based on their patent-pending bedside point-of-care C and GT production and ...
Lupagen avoids the cost & complexity of cell therapy and the safety & clinical challenges of viral-based gene therapy by a simple patient-connected gene delivery procedure done at the bedside. Our Side CAR-T® delivery system, a ...
based inPotsdam, GERMANY
Nanolytics specializes in Analytical Ultracentrifugation (AUC) and complementary methods, providing valuable analytical services to the pharmaceutical industry and beyond. With over 20 years of experience, they offer expertise in characterizing ...
based inPlanegg, GERMANY
TQ Therapeutics GmbH is pioneering a novel approach to cell and gene therapy with its TQx platform, which transforms the production of cellular therapies into a rapid, automated process that occurs at the patient's side. This method leverages ...
TQx is developing a modular target cell-specific modification platform including relevant technology components for the generation of gene modified cell therapy ...
based inCollege Station, TEXAS (USA)
Matica Biotechnology is a cell and gene therapy CDMO that is bringing together integrated GMP manufacturing platforms and innovative solutions resulting in speed to clinic without sacrificing quality. Our investments in advanced, single-use ...
At Matica Biotechnology’s 25,000-square-foot GMP facility in College Station, Texas, we offer fully integrated solutions for cell and gene therapies, vaccines, oncolytic vectors and other biotherapeutic ...
based inJerusalem, ISRAEL
Betalin Therapeutics licensed the novel Engineered Micro Pancreas (EMP) technology developed at The Hebrew University of Jerusalem, Israel, in an exclusive worldwide agreement in 2015. The Hebrew University continues to partner with Betalin ...
based inBall Ground, GEORGIA (US) (USA)
The MVE range of cryogenic freezers and aluminum dewars have been engineered for ultimate reliability and maximizing hold times at the ultra-low temperatures vital to the preservation of critical human and animal tissues and vaccines. We supply a ...
based inVienna, AUSTRIA
A spin-off from the University of Veterinary Medicine Vienna, ViruSure was founded in 2005 by Dr. Andy Bailey to offer a range of biosafety testing services to biopharmaceutical product manufacturers. Since 2008, ViruSure’s in vitro and molecular ...
Gene therapy has brought hope to many diseases with unmet clinical need. The potential to permanently cure the patient through replacement of a defective gene with a healthy gene underscores the surge of interest in this exciting biopharma ...
based inShanghai, CHINA
Bio-Link is a high-tech group enterprise that provides process solutions for the life science industry. We focus on the R&D and manufacturing of equipment and consumables in the production of recombinant protein drugs, vaccines, antibody drugs, cell ...
based inSomerset, NEW JERSEY (USA)
As the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world, we conduct all our business responsibly and with integrity. Our ...
Plasmid DNA is a critical raw material for advanced therapeutics including mRNA- and viral vector-based cell and gene therapies and vaccines. To support your therapeutic programs, the Catalent team has broad expertise in developing customized ...
based inFreiburg, GERMANY
Sartorius CellGenix is a leading global supplier of high quality raw and ancillary materials for the expanding market of cell and gene therapy and regenerative medicine. We develop, manufacture and market human cytokines, growth factors, and other ...
CellGenix® Recombinant Human EGF reliably promotes the expansion of mesenchymal stem cells (MSCs). It in addition promotes the differentiation of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs)-derived hepatoblasts. ...
based inCambridge, MASSACHUSETTS (USA)
Editas Medicine is a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around ...
In fact, we are at an inflection point where we are seeing the first real genomic medicines emerge to help patients. Advances in the scientific fields of cell therapy and gene therapy have paved the ...
based inAllendale, NEW JERSEY (USA)
We are a leading global contract development and manufacturing organization (CDMO) dedicated to the advancement and manufacturing of gene and cell therapy products. Minaris Regenerative Medicine is a leading global contract development and ...
Minaris Regenerative Medicine’s manufacturing development services help you to design efficient and robust manufacturing processes for your cell and gene therapy. Keeping the ultimate goal of commercial supply in mind, we help you think beyond ...